BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23582414)

  • 1. Percutaneous revascularization and long term clinical outcomes of diabetic patients randomized in the Occluded Artery Trial (OAT).
    Overgaard CB; Džavík V; Buller CE; Liu L; Banasiak W; Devlin G; Maggioni AP; Leor J; Burton JR; Reis G; Ruzyllo W; Forman SA; Lamas GA; Hochman JS;
    Int J Cardiol; 2013 Oct; 168(3):2416-22. PubMed ID: 23582414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of outcome and the lack of effect of percutaneous coronary intervention across the risk strata in patients with persistent total occlusion after myocardial infarction: Results from the OAT (Occluded Artery Trial) study.
    Kruk M; Kadziela J; Reynolds HR; Forman SA; Sadowski Z; Barton BA; Mark DB; Maggioni AP; Leor J; Webb JG; Kapeliovich M; Marin-Neto JA; White HD; Lamas GA; Hochman JS
    JACC Cardiovasc Interv; 2008 Oct; 1(5):511-20. PubMed ID: 19194534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart failure in post-MI patients with persistent IRA occlusion: prevalence, risk factors, and the long-term effect of PCI in the Occluded Artery Trial (OAT).
    Jhaveri RR; Reynolds HR; Katz SD; Jeger R; Zinka E; Forman SA; Lamas GA; Hochman JS
    J Card Fail; 2012 Nov; 18(11):813-21. PubMed ID: 23141853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of benefit with percutaneous intervention for late persistent occlusion after myocardial infarction: summary of the occluded artery trial.
    Gimple S; Menon V
    J Cardiovasc Nurs; 2008; 23(1):30-3. PubMed ID: 18158504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late coronary intervention for totally occluded left anterior descending coronary arteries in stable patients after myocardial infarction: Results from the Occluded Artery Trial (OAT).
    Malek LA; Reynolds HR; Forman SA; Vozzi C; Mancini GB; French JK; Dziarmaga M; Renkin JP; Kochman J; Lamas GA; Hochman JS
    Am Heart J; 2009 Apr; 157(4):724-32. PubMed ID: 19332202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infarct artery distribution and clinical outcomes in occluded artery trial subjects presenting with non-ST-segment elevation myocardial infarction (from the long-term follow-up of Occluded Artery Trial [OAT]).
    Menon V; Ruzyllo W; Carvalho AC; Almeida de Sousa JM; Forman SA; Jaworska K; Lamas GA; Roik M; Thuaire C; Turgeman Y; Hochman JS
    Am J Cardiol; 2013 Apr; 111(7):930-5. PubMed ID: 23351464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causes of death in early MI survivors with persistent infarct artery occlusion: results from the Occluded Artery Trial (OAT).
    Lang IM; Forman SA; Maggioni AP; Ruzyllo W; Renkin J; Vozzi C; Steg PG; Hernandez-Garcia JM; Zmudka K; Jimenez-Navarro M; Sopko G; Lamas GA; Hochman JS
    EuroIntervention; 2009 Nov; 5(5):610-8. PubMed ID: 20142183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological effects of late percutaneous coronary intervention for infarct-related coronary artery occlusion: the Occluded Artery Trial-Electrophysiological Mechanisms (OAT-EP).
    Rashba EJ; Lamas GA; Couderc JP; Hollist SM; Dzavik V; Ruzyllo W; Fridrich V; Buller CE; Forman SA; Kufera JA; Carvalho AC; Hochman JS;
    Circulation; 2009 Feb; 119(6):779-87. PubMed ID: 19188505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarction.
    Hochman JS; Reynolds HR; Dzavík V; Buller CE; Ruzyllo W; Sadowski ZP; Maggioni AP; Carvalho AC; Rankin JM; White HD; Goldberg S; Forman SA; Mark DB; Lamas GA;
    Circulation; 2011 Nov; 124(21):2320-8. PubMed ID: 22025606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of timing, location and definition of reinfarction on mortality in patients with totally occluded infarct related arteries late after myocardial infarction.
    Adlbrecht C; Huber K; Reynolds HR; Carvalho AC; Džavík V; Steg PG; Liu L; Marino P; Pearte CA; Rankin JM; White HD; Lamas GA; Hochman JS
    Int J Cardiol; 2014 Jun; 174(1):90-5. PubMed ID: 24726166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous coronary intervention in the Occluded Artery Trial: procedural success, hazard, and outcomes over 5 years.
    Buller CE; Rankin JM; Carere RG; Buszman PE; Pfisterer ME; Dzavik V; Thomas B; Forman S; Ruzyllo W; Mancini GB; Michalis LK; Abreu PF; Lamas GA; Hochman JS
    Am Heart J; 2009 Sep; 158(3):408-15. PubMed ID: 19699864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery Trial.
    Menon V; Pearte CA; Buller CE; Steg PG; Forman SA; White HD; Marino PN; Katritsis DG; Caramori P; Lasevitch R; Loboz-Grudzien K; Zurakowski A; Lamas GA; Hochman JS
    Eur Heart J; 2009 Jan; 30(2):183-91. PubMed ID: 19028780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of short-term symptomatic benefit in patients with an occluded infarct artery is unrelated to non-protocol revascularization: results from the Occluded Artery Trial (OAT).
    Devlin G; Reynolds HR; Mark DB; Rankin JM; Carvalho AC; Vozzi C; Sopko G; Caramori P; Džavík V; Ragosta M; Forman SA; Lamas GA; Hochman JS
    Am Heart J; 2011 Jan; 161(1):84-90. PubMed ID: 21167338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
    Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
    Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: results from long-term follow-up of the Occluded Artery Trial (OAT) cohort.
    White HD; Reynolds HR; Carvalho AC; Pearte CA; Liu L; Martin CE; Knatterud GL; Džavík V; Kruk M; Steg PG; Cantor WJ; Menon V; Lamas GA; Hochman JS
    Am Heart J; 2012 Apr; 163(4):563-71. PubMed ID: 22520521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of left ventricular ejection fraction on clinical outcomes over five years after infarct-related coronary artery recanalization (from the Occluded Artery Trial [OAT]).
    Kruk M; Buller CE; Tcheng JE; Dzavík V; Menon V; Mancini GB; Forman SA; Kurray P; Busz-Papiez B; Lamas GA; Hochman JS
    Am J Cardiol; 2010 Jan; 105(1):10-6. PubMed ID: 20102883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of late results of percutaneous coronary intervention among stable patients ≤65 versus >65 years of age with an occluded infarct related artery (from the Occluded Artery Trial).
    Skolnick AH; Reynolds HR; White HD; Menon V; Carvalho AC; Maggioni AP; Pearte CA; Gruberg L; Azevedo RE; Schroeder E; Forman SA; Lamas GA; Hochman JS; Džavík V
    Am J Cardiol; 2012 Mar; 109(5):614-9. PubMed ID: 22172242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of late revascularization of a totally occluded coronary artery after myocardial infarction on mortality rates in patients with renal impairment.
    Hastings RS; Hochman JS; Dzavik V; Lamas GA; Forman SA; Schiele F; Michalis LK; Nikas D; Jaroch J; Reynolds HR
    Am J Cardiol; 2012 Oct; 110(7):954-60. PubMed ID: 22728005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal strategy of primary percutaneous coronary intervention for acute myocardial infarction due to unprotected left main coronary artery occlusion (OPTIMAL): study protocol for a randomised controlled trial.
    Gao Y; Zhang F; Li C; Dai Y; Yang J; Qu Y; Qian J; Ge J;
    Trials; 2019 Mar; 20(1):162. PubMed ID: 30850023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of percutaneous coronary intervention on biomarker levels in patients in the subacute phase following myocardial infarction: the Occluded Artery Trial (OAT) biomarker ancillary study.
    Kruk M; Menon V; Kądziela J; Sadowski Z; Rużyłło W; Janas J; Roik M; Opolski G; Zmudka K; Czunko P; Kurowski M; Busz-Papież B; Zinka E; Jablonski W; Jaworska K; Raczynska A; Skonieczny G; Forman S; Li D; Hochman J
    BMC Cardiovasc Disord; 2013 Oct; 13():91. PubMed ID: 24156746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.